|
Re: National Kidney Foundation -Abstract: BOM
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 05:16AM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
6
|
Resverlogix Corp.
|
Apr 01, 2020 06:18PM
|
|
Re: Heart Failure
|
4
|
Resverlogix Corp.
|
Apr 04, 2020 04:34PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
11
|
Resverlogix Corp.
|
May 19, 2020 06:17PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
2
|
Resverlogix Corp.
|
May 20, 2020 04:43PM
|
|
Re: Finance
|
9
|
Resverlogix Corp.
|
May 25, 2020 05:48PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 26, 2020 04:54PM
|
|
Re: Tweet from Prof Kausik Ray
|
|
Resverlogix Corp.
|
Jun 01, 2020 07:53PM
|
|
Re: Tweet from Prof Kausik Ray
|
2
|
Resverlogix Corp.
|
Jun 01, 2020 07:56PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
4
|
Resverlogix Corp.
|
Jun 08, 2020 10:47AM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
1
|
Resverlogix Corp.
|
Jun 08, 2020 05:43PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
3
|
Resverlogix Corp.
|
Jun 08, 2020 06:25PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 01:06PM
|
|
Re: Presentation is over
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 01:19PM
|
|
Re: Presentation is over
|
3
|
Resverlogix Corp.
|
Jun 09, 2020 01:26PM
|
|
Re: BOM 2 Trial
|
3
|
Resverlogix Corp.
|
Jun 10, 2020 02:53PM
|
|
Re: BOM 2 Trial
|
7
|
Resverlogix Corp.
|
Jun 10, 2020 05:37PM
|
|
Re: BOM 2 Trial
|
2
|
Resverlogix Corp.
|
Jun 11, 2020 09:29AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 13, 2020 05:15PM
|
|
Re: June 9th NR
|
1
|
Resverlogix Corp.
|
Jun 14, 2020 05:02PM
|
